These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33419089)

  • 1. CHD4 Predicts Aggressiveness in PTC Patients and Promotes Cancer Stemness and EMT in PTC Cells.
    Pratheeshkumar P; Siraj AK; Divya SP; Parvathareddy SK; Alobaisi K; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33419089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.
    Xu CB; Liu XS; Li JQ; Zhao X; Xin D; Yu D
    J Cell Biochem; 2019 Jun; 120(6):10830-10846. PubMed ID: 30706537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALDH5A1 acts as a tumour promoter and has a prognostic impact in papillary thyroid carcinoma.
    Deng XY; Gan XX; Feng JH; Cai WS; Wang XQ; Shen L; Luo HT; Chen Z; Guo M; Cao J; Shen F; Xu B
    Cell Biochem Funct; 2021 Mar; 39(2):317-325. PubMed ID: 32881051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth-associated protein 43 promotes thyroid cancer cell lines progression via epithelial-mesenchymal transition.
    Zheng C; Quan RD; Wu CY; Hu J; Lin BY; Dong XB; Xia EJ; Bhandari A; Zhang XH; Wang OC
    J Cell Mol Med; 2019 Dec; 23(12):7974-7984. PubMed ID: 31568662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA CASC2 expression is down- regulated in papillary thyroid cancer and promotes cell invasion by affecting EMT pathway.
    Zhou T; Zhong M; Zhang S; Wang Z; Xie R; Xiong C; Lv Y; Chen W; Yu J
    Cancer Biomark; 2018; 23(2):185-191. PubMed ID: 30175973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-599 promotes apoptosis and represses proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells via downregulation of Hey2-depentent Notch signaling pathway.
    Wang DP; Tang XZ; Liang QK; Zeng XJ; Yang JB; Xu J
    J Cell Physiol; 2020 Mar; 235(3):2492-2505. PubMed ID: 31565805
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Wen J; Lin B; Lin L; Chen Y; Wang O
    Aging (Albany NY); 2020 Aug; 12(16):16437-16456. PubMed ID: 32857728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defeating EpCAM(+) liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma.
    Nio K; Yamashita T; Okada H; Kondo M; Hayashi T; Hara Y; Nomura Y; Zeng SS; Yoshida M; Hayashi T; Sunagozaka H; Oishi N; Honda M; Kaneko S
    J Hepatol; 2015 Nov; 63(5):1164-72. PubMed ID: 26095183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-1271 inhibits the progression of papillary thyroid carcinoma by targeting IRS1 and inactivating AKT pathway.
    Chen Y; Hao SA; Jiang Y; Gao B; Tian WG; Zhang S; Guo LJ; Wang LL; Luo DL
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7989-7999. PubMed ID: 31599424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AEBP1 promotes papillary thyroid cancer progression by activating BMP4 signaling.
    Ju G; Xing T; Xu M; Zhang X; Sun Y; Mu Z; Sun D; Miao S; Li L; Liang J; Lin Y
    Neoplasia; 2024 Mar; 49():100972. PubMed ID: 38237535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing SIX1 inhibits epithelial mesenchymal transition through regulating TGF-β/Smad2/3 signaling pathway in papillary thyroid carcinoma.
    Min WP; Wei XF
    Auris Nasus Larynx; 2021 Jun; 48(3):487-495. PubMed ID: 33077306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linc00941 Is a Novel Transforming Growth Factor β Target That Primes Papillary Thyroid Cancer Metastatic Behavior by Regulating the Expression of Cadherin 6.
    Gugnoni M; Manicardi V; Torricelli F; Sauta E; Bellazzi R; Manzotti G; Vitale E; de Biase D; Piana S; Ciarrocchi A
    Thyroid; 2021 Feb; 31(2):247-263. PubMed ID: 32495722
    [No Abstract]   [Full Text] [Related]  

  • 13. CHD4-mediated loss of E-cadherin determines metastatic ability in triple-negative breast cancer cells.
    Luo CW; Wu CC; Chang SJ; Chang TM; Chen TY; Chai CY; Chang CL; Hou MF; Pan MR
    Exp Cell Res; 2018 Feb; 363(1):65-72. PubMed ID: 29305962
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Chen CZ; Wen JL; Lin BY; Zheng C; Quan RD; Zhang XH; Qu JM
    Biomark Med; 2020 Jul; 14(11):969-980. PubMed ID: 32940082
    [No Abstract]   [Full Text] [Related]  

  • 15. CHD4/NuRD complex regulates complement gene expression and correlates with CD8 T cell infiltration in human hepatocellular carcinoma.
    Shao S; Cao H; Wang Z; Zhou D; Wu C; Wang S; Xia D; Zhang D
    Clin Epigenetics; 2020 Feb; 12(1):31. PubMed ID: 32070428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eva-1 homolog A promotes papillary thyroid cancer progression and epithelial-mesenchymal transition via the Hippo signalling pathway.
    Lin BY; Wen JL; Zheng C; Lin LZ; Chen CZ; Qu JM
    J Cell Mol Med; 2020 Nov; 24(22):13070-13080. PubMed ID: 32969138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of RET gene mediated EGFR signaling pathway on epithelial-mesenchymal transition, proliferation and apoptosis of papillary thyroid carcinoma cells.
    Zhao YL; Yuan BQ; Shen GS
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8036-8047. PubMed ID: 32767330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABCG2/BCRP gene expression is related to epithelial-mesenchymal transition inducer genes in a papillary thyroid carcinoma cell line (TPC-1).
    Mato E; González C; Moral A; Pérez JI; Bell O; Lerma E; de Leiva A
    J Mol Endocrinol; 2014 Jun; 52(3):289-300. PubMed ID: 24643400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of long noncoding RNA SLC26A4-AS1 inhibits the epithelial-mesenchymal transition via the MAPK pathway in papillary thyroid carcinoma.
    Wang DP; Tang XZ; Liang QK; Zeng XJ; Yang JB; Xu J
    J Cell Physiol; 2020 Mar; 235(3):2403-2413. PubMed ID: 31556116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways.
    Yu ST; Zhong Q; Chen RH; Han P; Li SB; Zhang H; Yuan L; Xia TL; Zeng MS; Huang XM
    Cell Death Dis; 2018 Mar; 9(3):371. PubMed ID: 29515111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.